Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Google Cloud Announces Healthcare Data Engine to Enable Interoperability in Healthcare
Today, Google Cloud announced the private preview of Healthcare Data Engine, an end-to-end solution for healthcare […]
X-Vax Technology Appoints Varsha K. Jain, MD as Chief Clinical Development Officer
X-Vax Technology, Inc. (X-VAX®), a biotechnology company developing vaccines based on a new approach that […]
Amadeus Integrates IBM Digital Health Pass Into its Digital Health Verification Technology
IBM (NYSE: IBM) and Amadeus (MCE: AMS) today announced that they are working together to […]
First Treatment Approved in England for Advanced Bile Duct Cancer
The drug pemigatinib (Pemazyre) will now be an option for people with a rare type of bile […]
Access to Genetic Results Allows for More Personalised Cancer Treatments
Doctors in Wales are now able to access digital genetic test results for urgent cancer […]
Elevar Therapeutics Announces CEO Transition and New Board Appointment
Elevar Therapeutics, Inc. (“Elevar”), a fully integrated biopharmaceutical company built on the promise of elevating […]
19Labs, Doctory Bring Next Generation Telehealth Kiosks to the Middle East
The hospital-at-home trend is rapidly changing the healthcare industry globally and throughout the Gulf countries. […]
Cityzenith and SafelyThrive Digital Twin Tech Partnership Delivers Major Solution to 'COVID Delta' Variant
As the world reels from the threat of COVID-19’s new and highly contagious Delta variant, […]
Panakès Partners Announces the First Closing of its New 'Purple' Global Biotech/Medtech Fund at €150 Million ($180 Million)
Panakès Partners, the leading Italian venture capital firm in the Life Sciences sector, announces the […]
NHS England Announces New Innovative Medicines Fund to Fast-track Promising New Drugs
NHS patients are set to benefit from early access to potentially life-saving new medicines, including cutting-edge gene therapies, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more